e-learning
resources
Virtual 2020
Pre-Congress Content
Biomarkers and characterisation of immune response in respiratory infection
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
D. McCafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), B. Walker (Belfast (Belfast), United Kingdom)
Source:
Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Session:
Biomarkers and characterisation of immune response in respiratory infection
Session type:
E-poster session
Number:
2349
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. McCafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom), B. Walker (Belfast (Belfast), United Kingdom). Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum. 2349
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Development of a novel immunoassay for the measurement of active plasmin in patients with IPF
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
The development of a novel immunoassay for the quantification of active tryptase
Source: International Congress 2017 – Chronic airway disease: markers of disease impact
Year: 2017
Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Evaluating the sensitivity and specificity of NEATstik technology compared to an activity-based immunoassay in sputum samples from participants with COPD
Source: Eur Respir J, 55 (5) 1902412; 10.1183/13993003.02412-2019
Year: 2020
Investigating optimal sputum processing methods for active neutrophil elastase quantification
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017
Comparison of enzyme immunoassays for the measurement of soy aeroallergens
Source: Eur Respir J 2005; 26: Suppl. 49, 36s
Year: 2005
An innovative high sensitivity tool for active neutrophil elastase quantification
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021
Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019
Usefulness of whole blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay for the diagnosis of active tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase
Source: International Congress 2018 – Clinical and functional monitoring in airway disease
Year: 2018
Validation of TNF-α determinations by homogeneous time-resolved fluorescence A comparison between HTRF® and ELISA in human whole blood assays
Source: Eur Respir J 2003; 22: Suppl. 45, 228s
Year: 2003
Evaluation of novel sputum processing methods and sensitive detection techniques in allergic asthmatics
Source: Annual Congress 2009 - What is new in the regulation and monitoring of airway function?
Year: 2009
New enzyme linked immunosorbent assay using recombinant antigens from
Saccharopolyspora rectivirgula
for farmer‘s lung disease serodiagnosis
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019
Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010
Clinical evaluation of anti-glycopeptidelipid core immunoglobulin A antibody assay for serodiagnosis of pulmonary
Mycobacterium avium-intracellulare
complex (MAC) disease
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005
Identification of bacterial pulmonary infection by a PCR based rapid molecular diagnostic assay in bronchoalveolar lavage
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Rapid, simplified whole blood-based multiparameter assay to quantify and phenotype SARS-CoV-2-specific T-cells
Source: Eur Respir J, 59 (1) 2100285; 10.1183/13993003.00285-2021
Year: 2022
A novel, automated periostin assay; correlation with a commercial ELISA method and usability as an asthma biomarker
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept